Reunion Neuroscience Stock Working Capital
| REUNDelisted Stock | USD 1.12 0.01 0.90% |
Reunion Neuroscience fundamentals help investors to digest information that contributes to Reunion Neuroscience's financial success or failures. It also enables traders to predict the movement of Reunion Stock. The fundamental analysis module provides a way to measure Reunion Neuroscience's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Reunion Neuroscience stock.
Reunion |
Reunion Neuroscience Company Working Capital Analysis
Reunion Neuroscience's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Reunion Neuroscience Working Capital | 21.24 M |
Most of Reunion Neuroscience's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Reunion Neuroscience is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
CompetitionBased on the company's disclosures, Reunion Neuroscience has a Working Capital of 21.24 M. This is 95.01% lower than that of the Healthcare sector and 96.06% lower than that of the Biotechnology industry. The working capital for all United States stocks is 98.56% higher than that of the company.
Reunion Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Reunion Neuroscience's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Reunion Neuroscience could also be used in its relative valuation, which is a method of valuing Reunion Neuroscience by comparing valuation metrics of similar companies.Reunion Neuroscience is currently under evaluation in working capital category among its peers.
Reunion Fundamentals
| Return On Equity | -0.86 | |||
| Return On Asset | -0.27 | |||
| Current Valuation | (13.96 M) | |||
| Shares Outstanding | 11.72 M | |||
| Shares Owned By Insiders | 34.39 % | |||
| Shares Owned By Institutions | 50.65 % | |||
| Number Of Shares Shorted | 114.9 K | |||
| Price To Book | 0.49 X | |||
| Price To Sales | 2.80 X | |||
| Gross Profit | (4.29 M) | |||
| EBITDA | (17.15 M) | |||
| Net Income | (48.49 M) | |||
| Cash And Equivalents | 48.13 M | |||
| Cash Per Share | 4.14 X | |||
| Total Debt | 3.37 M | |||
| Current Ratio | 47.74 X | |||
| Book Value Per Share | 1.82 X | |||
| Cash Flow From Operations | (27.92 M) | |||
| Short Ratio | 1.92 X | |||
| Earnings Per Share | (2.51) X | |||
| Target Price | 9.39 | |||
| Number Of Employees | 16 | |||
| Beta | 4.21 | |||
| Market Capitalization | 13.01 M | |||
| Total Asset | 29.74 M | |||
| Retained Earnings | (91.48 M) | |||
| Working Capital | 21.24 M | |||
| Z Score | -3.04 | |||
| Net Asset | 29.74 M |
About Reunion Neuroscience Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Reunion Neuroscience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Reunion Neuroscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Reunion Neuroscience based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Reunion Neuroscience
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Reunion Neuroscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reunion Neuroscience will appreciate offsetting losses from the drop in the long position's value.Moving against Reunion Stock
| 0.77 | REGN | Regeneron Pharmaceuticals | PairCorr |
| 0.75 | NVO | Novo Nordisk AS | PairCorr |
| 0.75 | NONOF | Novo Nordisk AS | PairCorr |
| 0.71 | QSAM | Qsam Biosciences | PairCorr |
| 0.63 | EPGG | Empire Global Gaming | PairCorr |
The ability to find closely correlated positions to Reunion Neuroscience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Reunion Neuroscience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Reunion Neuroscience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Reunion Neuroscience to buy it.
The correlation of Reunion Neuroscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Reunion Neuroscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Reunion Neuroscience moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Reunion Neuroscience can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Consideration for investing in Reunion Stock
If you are still planning to invest in Reunion Neuroscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Reunion Neuroscience's history and understand the potential risks before investing.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |